Securecell and Beckman Coulter Life Sciences team up to automate cell culture monitoring
The collaboration aims to reduce manual steps from sampling to data analysis
Advertisement
Securecell and Beckman Coulter Life Sciences are collaborating on the integration of the Vi-CELL BLU Cell Viability Analyzer with Securecell's Numera® 3 automated sampling platform, creating a more automated workflow for cell culture monitoring.
The new integration will combine automated liquid sample transfer with digital connectivity to enable a more seamless workflow from bioreactor sampling to cell analysis and process data.
As part of the collaboration, Securecell will develop a hardware interface to automate liquid sample transfer from Numera® to the Vi-CELL BLU analyzer , along with a software integration involving Lucullus®. The goal is to connect automated bioprocess sampling, cell analysis, and process data within one coordinated workflow.
Connecting Sampling, Analysis, and Process Data
Cell concentration and viability are essential measurements throughout cell culture process development. However, obtaining these measurements frequently requires operators to manually collect samples, perform manual sample processing steps, transport them to an analyzer, initiate measurements, and subsequently transfer or consolidate the resulting data. The planned Numera®–Vi-CELL BLU integration is designed to reduce these manual steps.
By connecting analytical results directly with the corresponding process information, scientists can evaluate cell growth and viability alongside other critical bioprocess parameters without relying on disconnected manual workflows.
From Automated Sampling to Connected Process Knowledge
“Automating sample collection is only part of the challenge. The real value emerges when sampling, analytical instruments, and process information can operate as one connected workflow,” said Boris Hamouda, Head Numera Operations, Securecell . “By combining Numera® with the Vi-CELL BLU analyzer and integrating the workflow with Lucullus®, we aim to make important cell culture information available with significantly less manual intervention.”
Daniel Koeffers, Senior Manager Cell Culture Products, Beckman Coulter Life Sciences: “We are committed to helping biopharmaceutical companies make faster, more confident decisions throughout process development and manufacturing. Our collaboration with Securecell brings together advanced bioprocess monitoring and trusted cell viability analytics, enabling customers to gain deeper insights into cell culture performance while streamlining their workflows. By combining Securecell's expertise in bioprocess data with the proven capabilities of Vi-CELL BLU, we are helping customers improve process understanding, increase efficiency, and accelerate innovation.”
Development Underway
Development of the software and hardware interfaces is currently underway and expected to be released within about 9 months . Securecell and Beckman Coulter will work together on the technical integration and evaluation of the workflow.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.